Browsing Category
Pharma Industry News
4766 posts
Business-News-Today.com section for global pharma industry news, Indian pharma sector latest news, pharma sector news today, pharmaceuticals industry news.
Gilead Sciences lenacapavir shows potential in transforming HIV clinical care
New data presented by Gilead Sciences, Inc. has highlighted the efficacy, safety, and patient tolerability of Sunlenca (lenacapavir),…
Sosei Group acquires Idorsia’s Japanese and Korean pharma units
Sosei Group Corporation has announced its decision to acquire all shares of Idorsia Pharmaceuticals Japan Ltd (“IPJ”) and…
Aarti Drugs Limited announces 6% YoY revenue growth in Q1 FY24
For the quarter ending 30th June 2023, Mumbai-based pharmaceutical company, Aarti Drugs Limited, announced its audited financial results,…
Padagis acquires former Emilia cosmetics facility in Yerucham, Israel
Padagis, a provider of extended topical and specialty pharmaceuticals, has increased its regional footprint with the acquisition of…
CHMP recommends approval for BeiGene’s tislelizumab in ESCC treatment
BeiGene, a global biotechnology firm, has revealed that the European Medicines Agency’s (EMA) Committee for Medicinal Products for…
CHMP endorses Merck’s gefapixant for EU approval for chronic cough treatment
The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended approval for gefapixant,…
Menarini’s ORSERDU gets CHMP positive opinion in advanced breast cancer
The Menarini Group and its subsidiary, Stemline Therapeutics Inc., have received a favorable opinion from the European Medicines…
Horizon Therapeutics’ Daxdilimab Phase 2 trial fails to reach primary endpoint in SLE
Horizon Therapeutics plc (Nasdaq: HZNP) announced that its Phase 2 clinical trial studying the efficacy of daxdilimab in…
Gilead Sciences discontinues Phase 3 ENHANCE Study on higher-risk MDS due to futility
Biopharmaceutical firm Gilead Sciences (Nasdaq: GILD) has announced the termination of its Phase 3 ENHANCE study in higher-risk…
Biopharma company AEON Biopharma goes public in SPAC deal
Priveterra Acquisition Corp., a special purpose acquisition company (SPAC) chaired by Robert Palmisano, has successfully completed its business…